Pesquisas alternativas:
nail company » rail company (Expandir a Pesquisa), oil company (Expandir a Pesquisa), retail company (Expandir a Pesquisa)
company cara » company car (Expandir a Pesquisa), company cars (Expandir a Pesquisa), company para (Expandir a Pesquisa)
ml compared » gel compared (Expandir a Pesquisa), oil compared (Expandir a Pesquisa), model compared (Expandir a Pesquisa)
compr can » comp can (Expandir a Pesquisa), computer can (Expandir a Pesquisa), compared can (Expandir a Pesquisa)
la compr » la compra (Expandir a Pesquisa), la compre (Expandir a Pesquisa), la combe (Expandir a Pesquisa)
cara new » cara e (Expandir a Pesquisa), cara de (Expandir a Pesquisa), cara n (Expandir a Pesquisa)
can non » dan non (Expandir a Pesquisa), than non (Expandir a Pesquisa)
3 nail » _ nail (Expandir a Pesquisa), a nail (Expandir a Pesquisa), 3 nacl (Expandir a Pesquisa)
j la » j a (Expandir a Pesquisa), j l (Expandir a Pesquisa), j da (Expandir a Pesquisa)
m ml » m m (Expandir a Pesquisa), m l (Expandir a Pesquisa), m al (Expandir a Pesquisa)
nail company » rail company (Expandir a Pesquisa), oil company (Expandir a Pesquisa), retail company (Expandir a Pesquisa)
company cara » company car (Expandir a Pesquisa), company cars (Expandir a Pesquisa), company para (Expandir a Pesquisa)
ml compared » gel compared (Expandir a Pesquisa), oil compared (Expandir a Pesquisa), model compared (Expandir a Pesquisa)
compr can » comp can (Expandir a Pesquisa), computer can (Expandir a Pesquisa), compared can (Expandir a Pesquisa)
la compr » la compra (Expandir a Pesquisa), la compre (Expandir a Pesquisa), la combe (Expandir a Pesquisa)
cara new » cara e (Expandir a Pesquisa), cara de (Expandir a Pesquisa), cara n (Expandir a Pesquisa)
can non » dan non (Expandir a Pesquisa), than non (Expandir a Pesquisa)
3 nail » _ nail (Expandir a Pesquisa), a nail (Expandir a Pesquisa), 3 nacl (Expandir a Pesquisa)
j la » j a (Expandir a Pesquisa), j l (Expandir a Pesquisa), j da (Expandir a Pesquisa)
m ml » m m (Expandir a Pesquisa), m l (Expandir a Pesquisa), m al (Expandir a Pesquisa)
1
Por Lima, J.C., Clark, M., Schwartz, M.L., Berridge, C., Tyler, D., Shield, R., Lepore, M., Miller, S.C.
Publicado no Innov Aging (2017)
“...). Compared to T1 measures, on average NHs improved across all three domains....”Publicado no Innov Aging (2017)
Obter o texto integral
Obter o texto integral
Artigo
2
Por Mancini-Bourgine, M, Guillen, G, Michel, ML, Aguilar, JC
Publicado no Euroasian J Hepatogastroenterol (2014)
“... this article: Mancini-Bourgine M, Guillen G, Michel ML, Aguilar JC. Impact of the Immunogen Nature...”Publicado no Euroasian J Hepatogastroenterol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Anderson, DP, Ramsey, DSL, de Lisle, GW, Bosson, M, Cross, ML, Nugent, G
Publicado no N Z Vet J (2015)
“...Disease surveillance for the management of bovine tuberculosis (TB) in New Zealand has focussed...”Publicado no N Z Vet J (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Begley, Cecily M, Gyte, Gillian ML, Devane, Declan, McGuire, William, Weeks, Andrew
Publicado em 2011
“... mL) (average risk ratio (RR) 0.34, 95% confidence interval (CI) 0.14 to 0.87, three studies, 4636...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Begley, Cecily M, Gyte, Gillian ML, Devane, Declan, McGuire, William, Weeks, Andrew, Biesty, Linda M
Publicado no Cochrane Database Syst Rev (2019)
“... whether active management reduces the average risk of maternal severe primary PPH (more than 1000 mL...”Publicado no Cochrane Database Syst Rev (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Falchetti, A., Amedei, A., Masi, L., Giusti, F., Cavalli, L., Casentini, C., Brandi, M.L.
Publicado em 2010
“... over the years, going from initial clinical sign of OP, through the now superseded definition of VFs...”Publicado em 2010
Obter o texto integral
Artigo
7
“... trials, ‘usual care’ appears to now include aggressive, early fluid resuscitation with at least 20 mL/kg...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Hippen, K.L., O’Connor, R.S., Lemire, A.M., Saha, A., Hanse, E.A., Tennis, N.C., Merkel, S.C., Kelekar, A, Riley, J.L., Levine, B.L., June, C.H., Kean, L.S., MacMillan, M.L., Miller, J.S., Wagner, J.E., Munn, D.H., Blazar, B.R.
Publicado no Am J Transplant (2017)
“... disease (GVHD). Previously we demonstrated that plasmacytoid dendritic cell (pDC) indoleamine 2,3...”Publicado no Am J Transplant (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... changes seen with simple infusion of a single substrate in fasting. These data are now compared...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“...We compared the in vitro activity of BMS-181184, the first compound of a new class of antifungal...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“... tablet dosage form in the UK; however, an innovative oral liquid form, Teglutik(®) 5 mg/mL oral...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“...OBJECTIVES—Comparative gait analyses in neurological diseases interfering with locomotion...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“...-dimensional surfaces. We have now developed methods for examining neutrophil movement in a three-dimensional...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
“... to inhibit 50% of DNA synthesis, in EA/DR was 6.7 +/- 1.15 micrograms ml-1 compared to 2.8 +/- 0.72...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Nearmeen M Rashad, Hanan M Sabry, Ahmed F Gomaa, Amany M Ebaid, Hala G Abomandour, Reem M Allam
Publicado em 2019-01-01
“.... Vitamin D (VD) deficiency is now recognized as a pandemic disease. This study was designed to explore...”Publicado em 2019-01-01
Obter o texto integral
Artigo
16
“...) and checked for pathogenic leptospires. The results of these studies have now been carefully analysed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Goldstein, Ellie J. C., Citron, Diane M., Vreni Merriam, C., Tyrrell, Kerin, Warren, Yumi
Publicado em 1999
“...The activities of gemifloxacin (SB 265805, LB20304) and comparator agents were determined...”Publicado em 1999
Obter o texto integral
Obter o texto integral
Artigo
18
“... of their non-tolerance – 1 tablet (3.125 mg) in the morning and evening during the meal), cardio...”
Obter o texto integral
Obter o texto integral
Artigo
19
Por Wasilk, A., Callahan, J. D., Christopher-Hennings, J., Gay, T. A., Fang, Y., Dammen, M., Reos, M. E., Torremorell, M., Polson, D., Mellencamp, M., Nelson, E., Nelson, W. M.
Publicado em 2004
“.... Subsequently, a real-time PCR targeting the 3′ untranslated region of the PRRSV genome was compared with nPCR...”Publicado em 2004
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Goldstein, Ellie J. C., Citron, Diane M., Merriam, C. Vreni, Warren, Yumi, Tyrrell, Kerin
Publicado em 1999
“...The comparative activity of telithromycin (HMR 3647) against 419 human anaerobic isolates...”Publicado em 1999
Obter o texto integral
Obter o texto integral
Artigo